The binding of 9-hydroxyellipticine to calf thymus DNA, poly[d(A-T)](2
), and poly[d(G-C)](2) has been studied in detail by means of CD, line
ar dichroism, resonance light scattering, and molecular dynamics. The
transition moment polarizations of 9-hydroxyellipticine were determine
d in polyvinyl alcohol stretched film. Spectroscopic solution studies
of the DNA/drug complex are combined with theoretical CD calculations
using the final 50 ps of a series of molecular dynamics simulations as
input. The spectroscopic data shows 9-hydroxyellipticine to adopt two
main binding modes, one intercalative and the other a stacked binding
mode involving the formation of drug oligomers in the DNA major groov
e. Analysis of the intercalated binding mode in poly [d(A-T)](2) sugge
sts the 9-hydroxyellipticine hydroxyl group lies in the minor groove a
nd hydrogen bonds to water with the pyridine ring protruding into the
major groove. The stacked binding mode was examined using resonance li
ght scattering and it was concluded that the drug was forming small ol
igomer stacks rather than extended aggregates. Reduced linear dichrois
m measurements suggested a binding geometry that precluded a minor gro
ove binding mode where the plane of the drug makes a 45 degrees angle
with the plane of the bases. Thus it was concluded that the drug stack
s in the major groove. No obvious differences in the mode of binding o
f 9-hydroxyellipticine were observed between different DNA sequences;
however, the stacked binding mode appeared to be more favorable for ca
lf thymus DNA and poly[d(G-C)](2) than for poly[d(A-T)](2), an observa
tion that could be explained by the slightly greater steric hindrance
of the poly[d(A-T)](2) major groove. A strong concentration dependence
was observed for the two binding modes where intercalation is favored
at very low drug load with stacking interactions becoming more promin
ent as the drug concentration is increased. Even at DNA : drug mixing
ratios of 70:1 the stacked binding mode was still important for GC-ric
h DNAs. (C) 1998 John Wiley & Sons, Inc.